Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome

Clinical Biochemistry

Volumn 42, Issue 9, 2009, Pages 828-834

  Iversen, Kasper K ^a   Teisner, Ane S ^b   Teisner, Borge ^c   Kliem, Anette ^d   Thanning, Pia ^e   Nielsen, Henrik ^b   Clemmensen, Peter ^e   Grande, Peer ^e  

^a HILLERØD HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c London Bridge Fertility   (United Kingdom)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

Acute coronary syndrome; Biomarker; Pregnancy associated plasma protein A

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; YOUNG ADULT;

EID: 65549167804     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.01.011     Document Type: Article

References (30)

1. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 108 (2003) 1772-1778
2. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108 (2003) 1664-1672
3. Bayes-Genis A., Conover C.A., Overgaard M.T., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 345 (2001) 1022-1029
4. Cosin-Sales J., Christiansen M., Kaminski P., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 (2004) 1724-1728
5. Cosin-Sales J., Kaski J.C., Christiansen M., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur. Heart J. 26 (2005) 2093-2098
6. Elesber A.A., Conover C.A., Denktas A.E., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur. Heart J. 27 (2006) 1678-1684
7. Consuegra-Sanchez L., Petrovic I., Cosin-Sales J., Holt D.W., Christiansen M., and Kaski J.C. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin. Chim. Acta 391 (2008) 18-23
8. Brugger-Andersen T., Hetland O., Ponitz V., Grundt H., and Nilsen D.W. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thromb. Res. 119 4 (2006) 415-421
9. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Ferrer J., and Vargas M. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction. Clin. Biochem. 38 (2005) 180-182
10. Lund J., Qin Q.P., Ilva T., et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann. Med. 38 (2006) 221-228
11. Futterman L.G., and Lemberg L. Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A. Am. J. Crit. Care 11 (2002) 168-172
12. Khosravi J., Diamandi A., Krishna R.G., Bodani U., Mistry J., and Khaja N. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease. Clin. Biochem. 35 (2002) 531-538
13. Laterza O.F., Cameron S.J., Chappell D., Sokoll L.J., and Green G.B. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin. Chim. Acta 348 (2004) 163-169
14. Qin Q.P., Laitinen P., Majamaa-Voltti K., Eriksson S., Kumpula E.K., and Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand. Cardiovasc. J. 36 (2002) 358-361
15. Lund J., Qin Q.P., Ilva T., et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108 (2003) 1924-1926
16. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur. Heart J. 28 (2007) 1598-1660
17. J.G. Westergaard. Studies on pregnancy associated plasma protein-A (PAPP-A) in normal and abnormal pregnancy, 1987.
18. Andersen D.C., Koch C., Jensen C.H., Skjodt K., Brandt J., and Teisner B. High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J. Immunoassay Immunochem. 1 (2004) 17-30
19. Rossen M., Iversen K., Teisner A., Teisner B., Kliem A., and Grudzinskas G. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome. Clin. Biochem. 40 (2007) 478-484
20. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur. Heart J. 28 13 (2007) 1598-1660
21. Iversen K.K., Teisner A.S., Teisner B., et al. Pregnancy-associated plasma protein A in non-cardiac conditions. Clin. Biochem. 41 (2008) 548-553
22. Iversen K.K., Teisner A.S., Teisner B., et al. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. Am. J. Cardiol. 101 (2008) 1389-1394
23. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
24. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
25. Lin T.M., Galbert S.P., Kiefer D., Spellacy W.N., and Gall S. Characterization of four human pregnancy-associated plasma proteins. Am. J. Obstet. Gynecol. 118 (1974) 223-236
26. Sinosich M.J., Teisner B., Folkersen J., Saunders D.M., and Grudzinskas J.G. Radioimmunoassay for pregnancy-associated plasma protein A. Clin. Chem. 28 (1982) 50-53
27. Wald N., Stone R., Cuckle H.S., et al. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ 305 (1992) 28
28. Schoos M., Iversen K., Teisner A., et al. Release patterns of pregnancy-associated plasma protein A in patients with acute coronary syndromes assessed by an optimized monoclonal antibody assay. Scand. J. Clin. Lab. Invest. 69 1 (2009) 121-127
29. Qin Q.P., Kokkala S., Lund J., et al. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin. Chem. 52 (2006) 398-404
30. Wittfooth S., Qin Q.P., Lund J., et al. Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A. Clin. Chem. 52 (2006) 1794-1801